These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31217523)

  • 41. Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens.
    Yılmaz GR; Baştuğ AT; But A; Yıldız S; Yetkin MA; Kanyılmaz D; Akıncı E; Bodur H
    J Infect Chemother; 2013 Feb; 19(1):57-62. PubMed ID: 22806446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Randomized Clinical Trial Evaluating the Efficacy of Colistin Loading Dose in Critically Ill Children.
    Fatehi S; Eshaghi H; Sharifzadeh M; Mirrahimi B; Qorbani M; Tanzifi P; Gholami K; Faghihi T
    J Res Pharm Pract; 2019; 8(4):196-201. PubMed ID: 31956632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
    Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
    Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colistin nephrotoxicity in the ICU: Is it different in the geriatric patients?
    Aydoğan BB; Yıldırım F; Zerman A; Gönderen K; Türkoğlu M; Aygencel G
    Aging Clin Exp Res; 2018 Jun; 30(6):573-580. PubMed ID: 28866836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia.
    Omrani AS; Alfahad WA; Shoukri MM; Baadani AM; Aldalbahi S; Almitwazi AA; Albarrak AM
    Ann Clin Microbiol Antimicrob; 2015 Jan; 14():3. PubMed ID: 25591721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
    Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of colistin in critically ill children in a pediatric intensive care unit.
    Karbuz A; Özdemir H; Yaman A; Kocabaş BA; Odek Ç; Güriz H; Aysev AD; Çiftçi E; Kendirli T; Ateş C; İnce E
    Pediatr Infect Dis J; 2014 Jan; 33(1):e19-24. PubMed ID: 24346607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
    Dickstein Y; Leibovici L; Yahav D; Eliakim-Raz N; Daikos GL; Skiada A; Antoniadou A; Carmeli Y; Nutman A; Levi I; Adler A; Durante-Mangoni E; Andini R; Cavezza G; Mouton JW; Wijma RA; Theuretzbacher U; Friberg LE; Kristoffersson AN; Zusman O; Koppel F; Dishon Benattar Y; Altunin S; Paul M;
    BMJ Open; 2016 Apr; 6(4):e009956. PubMed ID: 27098822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.
    Kontopidou F; Plachouras D; Papadomichelakis E; Koukos G; Galani I; Poulakou G; Dimopoulos G; Antoniadou A; Armaganidis A; Giamarellou H
    Clin Microbiol Infect; 2011 Nov; 17(11):E9-E11. PubMed ID: 21939468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colistin: how should it be dosed for the critically ill?
    Landersdorfer CB; Nation RL
    Semin Respir Crit Care Med; 2015 Feb; 36(1):126-35. PubMed ID: 25643276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study.
    Rouby JJ; Poète P; Martin de Lassale E; Nicolas MH; Bodin L; Jarlier V; Korinek AM; Viars P
    Intensive Care Med; 1994; 20(3):187-92. PubMed ID: 8014284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
    Amat T; Gutiérrez-Pizarraya A; Machuca I; Gracia-Ahufinger I; Pérez-Nadales E; Torre-Giménez Á; Garnacho-Montero J; Cisneros JM; Torre-Cisneros J
    Clin Microbiol Infect; 2018 Jun; 24(6):630-634. PubMed ID: 28970161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between colistin dose and development of nephrotoxicity.
    Lee YJ; Wi YM; Kwon YJ; Kim SR; Chang SH; Cho S
    Crit Care Med; 2015 Jun; 43(6):1187-93. PubMed ID: 25756417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement Therapy.
    Menna P; Salvatorelli E; Mattei A; Cappiello D; Minotti G; Carassiti M
    Chemotherapy; 2018; 63(1):35-38. PubMed ID: 29334366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
    Garnacho-Montero J; Amaya-Villar R; Gutiérrez-Pizarraya A; Espejo-Gutiérrez de Tena E; Artero-González ML; Corcia-Palomo Y; Bautista-Paloma J
    Chemotherapy; 2013; 59(3):225-31. PubMed ID: 24356297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
    Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
    J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.